International Journal of Radiation Oncology*Biology*Physics
VerifiedJournal
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | United Kingdom |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
| Frequency | Monthly |
| Accepts contributed content | Yes |
Recent Articles
Search ArticlesAssessing the Economic Feasibility and Social Impact of Proton Therapy Implementation in Mexico and Latin America
Keywords proton therapy Latin America Mexico health technology assessment access to radiotherapy patient perspectives Get full text access Log in, subscribe or purchase for full access. References 1. Grau, C. ∙ Durante, M. ∙ Georg, D. ... Particle therapy in Europe Molecular Oncology. 2020; 14(7):1492-1499 Jul 4. Rosenblatt, E. ∙ Meghzifene, A. ∙ Belyakov, O. ... Relevance of Particle Therapy to Developing Countries International Journal of Radiation Oncology*Biology*Physics. 2016; 95(1):25-29 May 5.
Implementation of a radiation oncology incident learning system in a limited resource setting: risk analysis and safety culture
Get full text access Log in, subscribe or purchase for full access. References 1. Ford, E.C. ∙ LFdL, Santos ∙ Pawlicki, T. ... Consensus recommendations for incident learning database structures in radiation oncology Med Phys. 2012; 39(12) 2. Gabriel, P.E. ∙ Volz, E. ∙ Bergendahl, H.W. ...
Effect of Lithium Mouthwash on Oral Mucositis and Taste Dysfunction in Head and Neck Radiotherapy: The Phase I/II Clinical Trial.
Keywords Radiotherapy Oral mucositis Taste dysfunction Head and neck cancer Lithium Get full text access Log in, subscribe or purchase for full access. References 1. Colevas, A.D. ∙ Yom, S.S. ∙ Pfister, D.G. ... NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018 J Natl Compr Canc Netw. 2018; 16(5):479-490 2. Iovoli, A.J. ∙ Turecki, L. ∙ Qiu, M.L. ... Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer JAMA Netw Open. 2023; 6(10), e2337265 3.
Initial Experience with Special Medical Physics Consultations for Proton Re-Irradiation
Get full text access Log in, subscribe or purchase for full access. Reference 1. Rulach, R. ∙ Ball, D. ∙ Chua, K.L.M. ... An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer Adv Radiat Oncol. 2021; 6(2), 100653 2. Ng, W.T. ∙ Soong, Y.L. ∙ Ahn, Y.C. ...
Model-aided quantification of patient-specific benefit in mitigating radiation induced lymphopenia by particle therapy of cancer
Introduction Radiation-induced lymphopenia (RIL) is a frequently observed side effect of radiation therapy, characterized by a marked reduction in blood lymphocyte counts 1–3. As RIL correlates with poor overall survival (OS) and increased disease recurrence rates 2,4–8, it has clinical relevance, although this correlation is not necessarily causative.
Prediction of Side Effects from Breast Radiation Therapy – Integration of Clinical and Genomic Data
Keywords Side effect prediction Machine learning Feature selection predictive modelling Long Term toxicity Radiotherapy side effects Radiotherapy Breast Cancer Get full text access Log in, subscribe or purchase for full access. References 1. Barazzuol, L. ∙ Coppes, R.P. ∙ van Luijk, P. Prevention and treatment of radiotherapy-induced side effects Molecular Oncology. 2020; 14:1538-1554 2. Dilalla, V. ∙ Chaput, G. ∙ Williams, T. ...
Multimodal Artificial Intelligence System for Risk-Adapted Cancer Survivorship Surveillance: A Multicenter Target Trial Emulation
Keywords artificial intelligence cancer survivorship target trial emulation nasopharyngeal carcinoma Get full text access Log in, subscribe or purchase for full access. References 1. Liang, J-L ∙ Wen, Y-F ∙ Huang, Y-P ... A prognostic and predictive model based on deep learning to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage ii nasopharyngeal carcinoma: A retrospective multicenter study Radiother Oncol. 2025; 203, 110660 2.
Association Between Linear Energy Transfer Distribution and Local Recurrence in Recurrent Nasopharyngeal Carcinoma Reirradiated With Intensity-Modulated Carbon Ion Therapy
Introduction Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma originating in the nasopharyngeal mucosa, which is generally highly radiosensitive, with a 5-year overall survival (OS) rate ranging from 80% to 86%.1,2 Approximately 10% to 15% of patients develop recurrence or metastasis after initial treatment, with one-third experiencing locoregional recurrence alone.3 Reirradiation remains the commonly employed and effective therapeutic approach for locoregionally recurrent NPC.4,5...
Proton Radiation for Locally Advanced Breast Cancer: Evolution and Techniques
Keywords proton therapy breast cancer locally advanced breast cancer regional nodal irradiation pencil beam scanning cardiac sparing contouring Get full text access Log in, subscribe or purchase for full access. References 1. Lalani, N. ∙ Alqarni, S. ∙ Jimenez, RB. The Potential of Proton Therapy for Locally Advanced Breast Cancer: Clinical and Technical Considerations Curr Oncol. 2023; 30(3):2869-2878 2. MacDonald, S.M. ∙ Patel, S.A. ∙ Hickey, S. ...
Radiobiological and Treatment Planning Evidence Supporting Particle Therapy in Aggressive Breast Cancer
The migration ability of the TN-BC cells was followed for 42 hours after irradiation net of the baseline contribution. Radiation quality strongly influences cell behavior, with opposite effects observed between XR and particle irradiation (Figure 4.A and 4.B), in line with literature [12,13,15,54].